Article Details

CASI Pharmaceuticals (NASDAQ:CASI) Rating Reiterated by HC Wainwright

Retrieved on: 2018-02-13 14:22:30

Tags for this article:

Click the tags to see associated articles and topics

CASI Pharmaceuticals (NASDAQ:CASI) Rating Reiterated by HC Wainwright. View article details on hiswai:

Excerpt

<div>A number of hedge funds have recently modified their holdings of CASI. <b>Renaissance Technologies</b> LLC grew its stake in CASI Pharmaceuticals by 33.4% in the 4th quarter. <b>Renaissance Technologies</b> LLC now owns 150,600 shares of the biotechnology company's stock worth $489,000 after acquiring ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo